RESOURCES
Helpful resources
For your practice
Use this form to get your patients started with ONWARD.
Download this brochure to learn more about the benefits of ZILBRYSQ and how to initiate treatment for your patients.
Guide to Writing a Letter of Appeal
Download this guide for information on the appeal process, including a checklist that can be followed when creating a letter of medical appeal, and a sample letter that has information health plans often require.
Guide to Writing a Letter of
Medical Necessity
Download this guide for a checklist that can be followed when creating a letter of medical necessity, as well as a sample letter that includes the information health plans often require.
Prior Authorization/
Predetermination Checklist
Download this checklist as an educational resource regarding common prior authorization requirements for ZILBRYSQ.
This guide can help your patients understand how doctors assess the many ways gMG can affect their activities of daily living.
Download this brochure to learn how, in 2025, Medicare Part D changes will improve affordability for Medicare patients with drug coverage.
For your patients
Provide your patients with this guide to help them learn more about ONWARD personalized support.
Use this form to get your patients started with ONWARD.
Provide your patients with this guide to help them learn more about ONWARD personalized support.
Ensure your patients have access to the Instructions for Use before getting started with ZILBRYSQ.
Media library
ZILBRYSQ Mechanism of Action (MOA) video
See how ZILBRYSQ, a C5 inhibitor, specifically targets the complement cascade, preventing the assembly and activity of the membrane attack complex.1,2
The precise mechanism through which ZILBRYSQ exerts therapeutic effects in gMG is unknown.1
The precise mechanism through which ZILBRYSQ exerts therapeutic effects in gMG is unknown.1
ZILBRYSQ: A Clinically Proven Choice
RAISE and RAISE-XT clinical studies
Listen to Dr. Michael Weiss, an expert in gMG, discuss the RAISE clinical studies with a focus on the primary endpoints of Myasthenia Gravis Activities of Daily Living (MG-ADL) total score and long-term safety and tolerability.
ZILBRYSQ: A Targeted Choice
How ZILBRYSQ specifically targets the complement cascade
Watch Dr. Hannah Machemehl, an expert in gMG, discuss how ZILBRYSQ provides complement inhibition.
ZILBRYSQ: A Personal Choice
Self-administration for today’s adult patients with gMG
Watch Dr. Eduardo De Sousa discuss self-administration.
References:
- ZILBRYSQ [Prescribing Information]. Smyrna, GA: UCB, Inc.
- Howard JF Jr, Bresch S, Genge A, et al; RAISE Study Team. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, Phase 3 study. Lancet Neurol. 2023;22(5):395-406. doi:10.1016/S1474-4422(23)00080-7
